FBIO

Fortress Biotech, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-03-31

Figures on this page computed 2026-11-08 12:40 UTC

Last close

1.97USD

Market data, 2026-11-04

Except where said otherwise: 10-K for 2025, filed 2026-03-31

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001104659-26-037874
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-31
The filing itself
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001104659-26-037874
Reported in
USD
- 10-K for 2025, filed 2026-03-31
- 10-K for 2025, filed 2026-03-31
- 10-K for 2025, filed 2026-03-31
- 10-Q for 2025, filed 2026-08-13
- 10-K for 2025, filed 2026-03-31
- 10-Q for 2025, filed 2026-08-13
The filing itself
10.8%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001104659-26-037874
Reported in
USD
- 10-K for 2025, filed 2026-03-31
- 10-K for 2025, filed 2026-03-31
The filing itself
n/aFCF margin
We do not hold this figure for this company, so there is nothing to place.
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001104659-26-037874
Reported in
USD
- 10-K for 2025, filed 2026-03-31
- 10-K for 2025, filed 2026-03-31
- 10-K for 2025, filed 2026-03-31
The filing itself
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001104659-26-037874
Reported in
USD
- 10-K for 2025, filed 2026-03-31
- 10-Q for 2025, filed 2026-08-13
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Safety is the furthest below its sector's middle: 0.37 against 0.52 on the market's range.

All from 100

lens 2 of 9

Sales

384

2016-12-31 to 2025-12-31100 at the start384

Sales: 100.00 on 2016-12-31 to 383.87 on 2025-12-31, up 284%.

Shares in issue

512

2021-12-31 to 2025-12-31100 at the start512

Shares in issue: 100.00 on 2021-12-31 to 512.27 on 2025-12-31, up 412%.

Profit, where the first year is 100: n/aNot enough filed years carry this line for it to be drawn. No line is drawn flat in its place.

Sales is at 384, Shares in issue is at 512, against 100 in 2016.

Every figure in this lens

Except where said otherwise: 10-K for 2025, filed 2026-03-31

Sales, where the first year is 100384
Source
filed
Statement
income
Fiscal year
2025
Accession
0001104659-26-037874
Reported in
USD
The filing itself
Profit, where the first year is 100n/a
Not held.
Source
filed
Statement
income
Fiscal year
2025
Accession
0001104659-26-037874
Reported in
USD
The filing itself
Shares in issue, where the first year is 100512
Source
filed
Statement
income
Fiscal year
2025
Accession
0001104659-26-037874
Reported in
USD
The filing itself